Atlas Trials

Safety, Tolerability and Pharmacokinetics (PK) Study of GSK2269557 in Healthy Subjects

Clinical trial NCT03189589 · COMPLETED

Trial details

NCT number
NCT03189589
Sponsor
GlaxoSmithKline
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pulmonary Disease, Chronic Obstructive
Start date
2017-06-15
Primary completion
2017-07-24
Enrollment
12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.